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The data provides information in support of the research article
Moraes et al., Atherosclerosis 243(2) (2015) 477–485 [1]. Here we
provide data behind the mechanisms involved in Angiotensin II
(Ang II) effects on vascular smooth muscle cells (VSMC). Ang II-
induced VSMC ROS production is modulated by alpha1beta1
integrin. Ang II also stimulates ROS production in VSMC via
p47phox, a NOX2 subunit. Furthermore, Ang II effect on VSMC
migration was also inhibited by NOX2 inhibitor. We showed that
obtustatin, alpha1beta1 integrin blocker, inhibited Ang II effect on
p47phox activation. Ang II effect on ROS production is also PI3K
dependent. Finally we showed that NOX1 and Integrin-Linked-
Kinase (ILK) are crucial to NOX2 activation. The research provides
information about the sequential events of NOX1/alpha1beta1
integrin/ILK/NOX2 in Ang II effects on VSMC.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
Fidalgo).
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ata accessibility The data presented in this article and is related to [1]Value of the data These data provides a thorough understanding the molecular events underlying Angiotensin II
effect on vascular smooth muscle cells.
 The data shows dual-NOX involvement in Angiotensin II effect on vascular smooth muscle cell: a
rapid NOX1 activation which is accompanied by NOX2.
 The data shows that Angiotensin II effect on NOX2 activation depends on NOX1 and ILK.
 These data also show that NOX2 is involved in Angiotensin II effect on vascular smooth muscle cell
migration.1. Data
1.1. Alpha1beta1 modulates the second interval of Ang II-induced ROS production in VSMC
Table 1 shows the detailed analysis of ROS production showed in Fig. 1B of Ref. [1]. This table
shows that ROS production induced in VSMC occurred in two stages, and that obtustatin inhibited
only the second part (0.5–1 h) of ROS production.econd interval of Ang II-induced ROS production in VSMC. Slope interval was calculated by Δy/Δx
Fig. 1B in Ref. [1]). Δy is the amount of ROS production in determined interval time. Δx is a time
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Fig. 1. Time-course of angiotensin II-induced ROS production and its dependence on NOX2 in VSMC. ROS production (assessed
by CM-H2DCFDA) was evaluated in primary VSMC incubated with angiotensin II (Ang II) 100 nM. Apocynin 10 mΜ was added
15 min before Ang II. The results are representative of three independent experiments. Data are expressed as means7SD.
*po0.05 vs. untreated; po0.05 vs. the treated with Ang II.
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Fig. 2. Angiotensin II induces VSMC migration via NOX2. Primary VSMC were incubated for 15 min with apocynin 10 mM and
cells were placed in modiﬁed Boyden chemotaxis chambers towards an angiotensin II (Ang II) 100 nM gradient for 4 h at 37 °C.
The results are representative of three independent experiments. Data are expressed as means7SD or SD. *po0.05 vs.
untreated; po0.05 vs. the treated with Ang II.
J.A. Moraes et al. / Data in Brief 6 (2016) 330–3403321.2. Time-course of angiotensin II-induced ROS production and its dependence on NOX2 in VSMC
Apocynin, a selective inhibitor of p47phox (a NOX2 subunit), inhibited only the second peak of ROS
(0.5–1 h) production induced by Ang II in VSMC (Fig. 1).1.3. Angiotensin II induces VSMC migration via NOX2
Ang II effect on VSMC migration also relies in NOX2 activity, once we observed that the pre-
treatment of VSMC with Apocynin inhibited the chemotactic effect of Ang II (Fig. 2).
IB: NOX 1 -
IB: NOX 2 -
IB: NOX 4 -
IB: Actin -
A7r5 PMN
Fig. 3. A7r5 contains NOX1, NOX2 and NOX4. A7r5 cells and human polymorphonuclear neutrophils were lysed and subjected
to SDS-PAGE and blotting for NOX1, NOX2, NOX4 and β-actin (load control) proteins. The results are representative of two
independent experiments.
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It is well described that VSMC contains NOX2 [2,3], so we investigated the presence of this protein
in the VSMC line A7r5. In our data we observed that besides NOX1 and NOX4, A7r5 also has NOX2 at
similar levels compared to polymorphonuclear neutrophils (Fig. 3).
1.5. p47phox and alpha1beta1 integrin modulate angiotensin II effect on NOX2 activation in VSMC
When p47phox interacts with the NOX2 membrane subunit, NOX2 becomes a full complex and it is
ready to initiate ROS production [4,5]. Fig. 4 shows that Ang II induced p47phox translocation to plasma
membrane and that apocynin and obtustatin inhibited this effect, indicating a dependence on p47phox
and alpha1beta1 integrin for Ang II-induced NOX2 activation.
1.6. Angiotensin II induces p47phox activation in VSMC
As we can observe through cytosol/membrane fraction analysis, Ang II was able to induce p47phox
translocation to VSMC membrane 10 min after treatment (Fig. 5A). Densitometry can be observed in
Fig. 5B.
1.7. Angiotensin II induces ROS production via PI3K/AKT in VSMC
The treatment of VSMC with LY294002, a PI3K-AKT inhibitor, impaired the second peak of ROS
production (after 30 min) induced by Ang II (Fig. 6).
1.8. siRNA silencing in VSMC
For the set of experiments using siRNA technique we used A7r5 rat aorta smooth muscle cell line,
which exhibit similar responses to Ang II when compared to primary VSMC (data not shown). Fig. 7A
shows the western blotting of whole cell lysate of cells transfected with the speciﬁc siRNA (ILK, NOX1
and NOX2) and blotted to ILK, NOX1, NOX2 and actin. Speciﬁc siRNA treatment induced, respectively,
50% inhibition in ILK and NOX1 expression and almost 80% reduction of NOX2 (Fig. 7B). It was not
possible to completely silence ILK and NOX1 expression since it caused cell death (data not shown).
1.9. ILK modulates the second interval of Ang II-induced ROS production in VSMC
Table 2 shows that Ang II was not able to induce any peak of ROS production in A7r5 silenced cells
to NOX1. Furthermore silencing to ILK just interfered with the second peak of ROS production induced
by Ang II.
Ang II
Obt + Ang IIObt
Ut
Apo + Ang IIApo
Fig. 4. p47phox and alpha1beta1 integrin modulate angiotensin II effect on NOX2 activation in VSMC. Primary VSMC obtained
from rat aorta untreated (top, left); treated with obtustatin (obt) 100 nM for 1 h (bottom, left); stimulated with Ang II 100 nM
for 1 h (top, right), or treated with obtustatin (100 nM) and stimulated with Ang II (bottom, right). p47phox membrane trans-
location was evaluated by immunoﬂuorescence staining with anti-p47phox-Alexa 388 (green), actin was visualized through
phalloidin-rodhamin (red) and nuclei was visualized through DAPI (blue). Scale bar: 10 μm. White arrows indicate p47phox
presence in cell membrane (yellow). Result is representative of three independent experiments.
J.A. Moraes et al. / Data in Brief 6 (2016) 330–3403341.10. NOX1 and integrin linked kinase (ILK) modulate angiotensin II effect on NOX2 activation in VSMC
Ang II was not able to induce NOX2 activation in A7r5 silenced cells to ILK or NOX1. On the other
hand, Ang II was able to activate NOX2 in A7r5 transfected with siRNA scramble (Fig. 8).
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Fig. 5. Angiotensin II induces p47phox activation in VSMC. Primary VSMC were treated with Angiotensin II (Ang II) 100 nM for
the indicated times at 37 °C/5% CO2, lysed and subjected to ultracentrifugation at 40,000g for 1 h. A. Cytosolic (C; the super-
natant) and membrane (M; the pellet) fractions (10 mg/lane) were subjected to SDS-PAGE and blotting for p47phox, β-actin
(cytosolic load control), and NOX2 (membrane load control) proteins. B. p47phox activation was measured by p47phox/NOX2
membrane ratio. The results are representative of two independent experiments.
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Fig. 6. Angiotensin II induces ROS production via PI3K/AKT in VSMC. Primary VSMC were incubated with LY294002 (50 μM) for
15 min at 37 °C/5% CO2. Angiotensin II (Ang II) 100 nM was added and ROS production was followed up to 3 h. Results are
representative of three independent experiments. Data are expressed as mean7SD. *po0.05 vs. untreated; po0.05 vs. the
treated with Ang II.
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Fig. 7. siRNA silencing in VSMC. A7r5 cells were transfected with siRNA to NOX1, NOX, ILK or siRNA scramble for 24 h. All
treatments were performed at 37 °C/5% CO2. A. Whole cell extracts were prepared and subjected to Western blotting for ILK,
NOX1, NOX2 and β-actin (load control). B. Effect of each siRNA on its respective target was quantiﬁed and it was showed in % of
silencing.
Table 2
ILK modulates the second interval of Ang II-induced ROS production in VSMC. Slope interval was calculated by Δy/Δx of ROS
production graph (see Figure 3B in Ref. [1]). Δy is the amount of ROS production in determined interval time. Δx is a time
interval of 30 min.
Control Ang II
Time interval (min) siRNA scramble siRNA NOX1 siRNA ILK siRNA scramble siRNA NOX1 siRNA ILK
0–30 070.11 0.0370.13 070.08 0.970.11n 0.170.12# 0.8370.12n
30–60 070.2 070.11 0.0670.15 0.4370.17n 0.170.17# 0.0670.1#
Results are representative of three independent experiments. Data are expressed as means ± SD
n po0.05 vs. untreated.
# p o0.05 vs the treated with Ang II.
J.A. Moraes et al. / Data in Brief 6 (2016) 330–3403361.11. Alpha1beta1 integrin does not modulate Angiotensin II effect on mitochondrial ROS production in
VSMC
Ang II induced mitochondrial ROS production in VSMC after 3 h of treatment. We also observed
that this effect was not alpha1beta1 integrin dependent, once obtustatin was not able to inhibit Ang II
effect (Fig. 9).
siRNA scramble
Ang II
siRNA NOX1 siRNA ILK
siRNA scramble siRNA NOX1 siRNA ILK
Fig. 8. NOX1 and integrin linked kinase (ILK) modulate angiotensin II effect on NOX2 activation in VSMC. A7r5 cells were
transfected with siRNA to NOX1, ILK or siRNA scramble for 24 h. All treatments were performed at 37 °C/5% CO2. A7r5 cells were
stimulated with Ang II 100 nM for 1h. p47phox membrane translocation was evaluated by immunoﬂuorescence staining with
anti-p47phox-Alexa 388 (green), actin was visualized using phalloidin-rodhamin (red) and nuclei was visualized using DAPI
(blue). Scale bar: 10 μm. White arrows indicate p47phox presence in cell membrane (yellow). Result is representative of three
independent experiments.
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Fig. 9. Alpha1beta1 integrin does not modulate Angiotensin II effect on mitochondrial ROS production in VSMC. Primary VSMC
were incubated with obtustatin (Obt) 100 nM for 15 min at 37 °C/5% CO2. Angiotensin II (Ang II) 100 nM was added and
mitochondrial ROS production (assessed using MitoSox, an indicator of mitochondrial ROS production) was followed up to 3 h.
Results are representative of three independent experiments. Data are expressed as mean7SD. *po0.05 vs. untreated;
po0.05 vs. the treated with Ang II.
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Fig. 10. Proposed model. Ang II-induced ROS production is NOXs dependent and the initial ROS production induced by NOX1
leads to NOX2 activation, which sustains the effect. Alpha1beta1 integrin/ILK crosstalk is a link between NOX1 and NOX2
activation, which in turn is responsible for Ang II-induced VSMC migration and proliferation.
J.A. Moraes et al. / Data in Brief 6 (2016) 330–3403381.12. Proposed model
Taking together this data and Ref. [1], Ang II modulates signaling pathways involved in chemotaxis
and proliferation in vascular smooth muscle cells. Ang II induces a rapid ROS production via NOX1.
This initial and rapid ROS production activates alpha1beta1 integrin, which in turn activates FAK.
Once activated, FAK dissociates to ILK, which activates AKT and induces p21 degradation. AKT pro-
motes p47phox engagement do NOX2 membrane subunit, allowing NOX2 complex activation, leading
to ROS production that is responsible for cell migration and partially to cell proliferation (Fig. 10).2. Experimental design, materials and methods
2.1. Cell culture
Primary VSMC were isolated from the aortic arch from naïve Wistar male rats using an explant
method. In brief, rats were anesthetized and the thoracic aorta was harvested, opened longitudinally,
scraped free of endothelium, cut into small pieces and treated for 30 min with collagenase. The
endothelium-denuded tissue was placed with the luminal surface facing down on a 0.1% gelatin-
coated ﬂask with DMEM medium containing 10% FBS, 50 U/mL penicillin and 100 mg/mL strepto-
mycin, and cultured at 37 °C/ 5% CO2 air atmosphere. After 7–14 days, the VSMC that outgrowth from
the explants were trypsinized and used in different assays until passage three. These cells were
positive stained for VSMC α-actin. This study was carried out in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Committee on the Ethics of Animal Experimental of Uni-
versidade do Estado do Rio de Janeiro. (Permit number: CEUA/003/2013).
A7r5 VSMC, obtained from rat thoracic aorta (ATCC, Rockville, MD) were cultured in DMEM
medium containing 10% FBS, 50 U/mL penicillin and 100 mg/mL streptomycin, and incubated at 37 °C
in a 5% CO2 air atmosphere. The cells were dissociated with 0.1%/0.01% trypsin/EDTA and then seeded
onto new culture ﬂasks for a maximum of twelve passages.
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A7r5 VSMC were transfected with either a non-targeting control siRNA (siRNA negative control 1;
Ambion, TX, USA) as a control for non-sequence-speciﬁc effects, or with an ILK (Silencer Pre designed
siRNA ILK ID 16708; Ambion), a NOX1-speciﬁc siRNA sequence (Silencer Predesigned siRNA NOX1 ID
55585; Ambion) or a NOX2-speciﬁc siRNA sequence (Silencer Predesigned siRNA NOX2 ID 647047;
Ambion). Twenty mM of either the non-targeting or ILK, NOX1 or NOX2-speciﬁc duplex were diluted
in 1 mL Opti-MEM I (Gibco,Grand Island, NY, USA) reduced serum medium and 1 mL of Lipofectamine
2000 (Ambion) diluted in Opti-MEM I was added. The mixture was gently mixed and allowed to
incubate for 5 min at room temperature, being the ﬁnal concentration of siRNA 10 mM. VSMC were
grown in 6-well plate culture and when at 70% of conﬂuence, RNAi duplex-Lipofectamine 2000
complexes in antibiotics and serum-free media was added. Twenty-four hours after transfection,
attenuation of ILK, NOX1 or NOX2 expression was veriﬁed by Western blotting of cell lysates probed
with antibody against ILK, NOX1 and NOX2.
2.3. Reactive oxygen species production
VSMC (510³ cells/well) were seeded in 96 wells plate overnight in DMEM medium containing
10% FBS. The cells were washed three times with PBS and the medium was replaced by DMEM
containing 1% FCS for 1 h. VSMC were loaded with 10 mM CM-H2DCFDA (intracellular ROS) or with
10 mM MitoSox Red (mitochondrial-derived ROS) for 1 h and then washed to remove free probe. Cells
were pretreated with 100 nM obtustatin or 10 mM apocynin for 15 min, and then incubated with Ang
II 100 nM for 3 h at 37 °C. CM-H2DCFDA ﬂuorescence was monitored at excitation and emission
wavelengths of 495 and 530 nm, respectively and MitoSox Red ﬂuorescence was monitored at exci-
tation and emission wavelengths of 510 and 580 nm, respectively. Fluorescence was quantiﬁed using
an EnVisions multilabel plate reader (Perkin-Elmer, Waltham, MA, USA). Slope intervals showed in
tables were calculated by Δy/Δx of ROS production graph. Δy is the amount of ROS production in
determined interval time. Δx is a time interval of 30 min.
2.4. Cell migration assay
For cell migration (chemotaxis) analysis in vitro, VSMC were seeded at a density of 2105 cells/
well in 48-well modiﬁed Boyden chambers containing a polycarbonate membrane (pore size, 10 mm;
Neuroprobe, Inc., Gaithersburg, MD, USA), and incubated at 37 °C in a 5% CO2 atmosphere for 4 h.
Some cell samples were treated with 10 mM Apocynin for 15 min before addition to the upper
chamber (50 mL), and VSMC migrated toward 100 nM Ang II (in lower chamber). The cells that
migrated to the lower membrane surface were ﬁxed and stained using Wright-Giemsa stain and
counted by light microscopy (400 ), in an Olympus BX41 light microscope (Tokyo, Japan).
2.5. Cellular Extract
For whole cell extracts, VSMC were lysed in 50 mM HEPES, pH 6.4, 1 mM MgCl2, 10 mM EDTA, 1%
Triton X-100, 1 mg/mL DNase, 0.5 mg/mL Rnase, 1 mM PMSF, 1 mM benzamidine, 1 mg/mL leupeptin
and 1 mg/mL soybean trypsin inhibitor. For cell membrane isolation, VSMC were lysed in HES buffer
(25 mM Hepes, pH 7.3, 1 mM EDTA, 0.25 M sucrose, aprotinin (10 mg/mL), leupeptin (10 mg/mL),
pepstatin (2 mg/mL), and 1 mM PMSF). Lysates were ultracentrifuged at 40.000g for 1 h at 4 °C. Then,
the supernatant was collected (cytosol fraction) and the pellet (membrane fraction) was ressus-
pended in HES buffer.
2.6. SDS-PAGE and immunoblotting
Total protein content in the cell extracts was determined by BCA method. Cell lysates were
denatured in sample buffer (50 mM Tris HCl, pH 6.8, 1% SDS, 5% 2-ME, 10% glycerol, and 0.001%
bromophenol blue) and heated in boiling water for 3 min. Samples (30 mg total protein) were resolved
J.A. Moraes et al. / Data in Brief 6 (2016) 330–340340by 12% SDS-PAGE and proteins transferred to polyvinylidinediﬂuoride membranes. Molecular weight
standards were run in parallel. Membranes were blocked with Tween-TBS (TBS, 0.01% Tween 20;
T-TBS) containing 1% BSA and probed with primary antibody (1:1000) overnight at 4 °C. Primary
antibodies used in western analysis were anti-NOX1 cat: 131088 (Abcam, Cambridge MA, USA), anti-
actin cat: 1501, anti-p47phox cat: 07–497 (Millipore,Billerica, MA, USA), anti-GP91phox (NOX2) cat:
20782, anti-NOX4 cat: 21860 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The membranes were
rinsed with T-TBS and incubated for 1 h at room temperature with biotin-conjugated secondary
antibody (1:10,000), followed by incubation with HRP-conjugated streptavidin (1:10,000). Immu-
noreactive proteins were visualized by the ECL detection. Western blotting signals were quantiﬁed by
densitometry, using the ImageJ Software (NIH, Bethesda, MD, USA).Conﬂict of interest
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